Jessica Kung
Gerontology · Daly City, CANPI 1790438075
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 136 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $1,374 and has fallen 61.4% since, to $531 in 2025.
Across 136 payments — averaging $21.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$643
- Novo Nordisk$550
- Boehringer Ingelheim$535
- Lilly USA, LLC$329
- Exact Sciences$201
- Amgen$186
- plus $528 from 10 others
What the payments were for
- Food & beverage$2,974100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 29 | $643 |
| Novo Nordisk | 29 | $550 |
| Boehringer Ingelheim | 26 | $535 |
| Lilly USA, LLC | 13 | $329 |
| Exact Sciences | 8 | $201 |
| Amgen | 8 | $186 |
| GSK | 5 | $101 |
| Pfizer | 3 | $79 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $78 |
| Lexicon Pharmaceuticals, Inc. | 3 | $76 |
| Viiv Healthcare Company | 2 | $55 |
| Merck | 2 | $39 |
| Corcept Therapeutics | 1 | $29 |
| Bayer | 1 | $26 |
| Esperion Therapeutics, Inc. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
How this compares
$2,974 in reported general payments places this provider in the 85th percentile of 348 gerontology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 78 | $113,149 |
| OzempicSemaglutide | 65 | $63,913 |
| EliquisApixaban | 32 | $40,134 |
| JanuviaSitagliptin Phosphate | 27 | $39,120 |
| FarxigaDapagliflozin Propanediol | 27 | $33,086 |
| TrulicityDulaglutide | 26 | $25,959 |
| XareltoRivaroxaban | 18 | $17,837 |
| Atorvastatin Calcium | 423 | $4,942 |
| Levothyroxine Sodium | 211 | $3,816 |
| Losartan Potassium | 256 | $2,716 |
| Valsartan | 55 | $2,370 |
| Metoprolol Succinate | 120 | $2,218 |
| Irbesartan | 83 | $2,215 |
| Amlodipine Besylate | 336 | $2,080 |
| Wixela InhubFluticasone Propion/Salmeterol | 30 | $1,905 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $535 | $113,14978 claims |
| Novo NordiskOzempic | $550 | $63,91365 claims |
| PfizerEliquis | $79 | $40,13432 claims |
| MerckJanuvia | $39 | $39,12027 claims |
| AstraZenecaFarxiga | $643 | $33,08627 claims |
| Lilly USA, LLCTrulicity | $329 | $25,95926 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 348 gerontology providers in California.
Other gerontology in Daly City
- Lovely IsraelSanta Monica$95K
- Leslie TarlowLos Angeles$58K
- Christine PartamianPorter Ranch$41K
- Elsa Pineda-FloresLos Angeles$24K
- Maria MottaDuarte$23K
- Daniel ChiuOrange$17K
- Katiaryna KulinichChula Vista$15K
- Nataliya OsorioRiverside$13K
- Anne Marie de Joya ReeveDuarte$11K
- Wendy AlmonteLemoore$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.